About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Colorado | 364 Studies

Clinical Trials Prostate CancerColorado

Prostate Cancer Clinical Trials in Colorado

Find 364 clinical trials for prostate cancer near Colorado. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Colorado

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 161-180 of 364 trials

CompletedPhase 1/1b Study of MGCD516 in Patients With Advanced CancerMGCD516 is a receptor tyrosine kinase (RTK) inhibitor shown in preclinical models to inhibit a closely related spectrum of RTKs including MET, AXL, MER, and members of the VEGFR…NCT02219711·Birmingham, Alabama and 42 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedStudy of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate CancerThis study is being conducted to assess the safety and tolerability of relugolix with other agents approved for use in combination with androgen deprivation therapy (ADT) for a…NCT04666129·Tucson, Arizona and 15 others

CompletedStudy of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial CancerThe primary objective in Phase I is to evaluate the safety and tolerability of sacituzumab govitecan-hziy (SG) as a single agent administered in 21-day treatment cycles in…NCT01631552·Aurora, Colorado and 11 others

CompletedIMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific AntigenThe purpose of this study is to show that abiraterone acetate plus prednisone added to the current standard of care, gonadotropin-releasing hormone (GnRH) decreases prostate…NCT01314118·Homewood, Alabama and 44 others

WithdrawnStereotactic Body Radiotherapy (SBRT) With Concurrent Boost for Low- and Intermediate-Risk Prostate CancerThe purpose of this study is to determine whether stereotactic body radiation therapy (SBRT) with simultaneous boost (higher radiation dose) to areas within the prostate with more…NCT01409473·Aurora, Colorado and 1 other

RecruitingEvaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine TumorsThe objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic Small Cell Lung…NCT07080242·Huntsville, Alabama and 23 others

Active not recruitingTo Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close MonitoringThis phase II trial studies how well green tea catechins work in preventing progression of prostate cancer from a low risk stage to higher risk stages in men who are on active…NCT04597359·Fairbanks, Alaska and 352 others

TerminatedA Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid TumorsThis study is an open-label, multi-center, dose-escalation, dose expansion study in adult subjects with advanced solid tumors.NCT05084859·Tucson, Arizona and 19 others

CompletedA Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.An open-label, multicenter, Phase 1b/2 study to identify the recommended Phase 2 dose and assess the efficacy and safety of BXCL701 administered orally, as monotherapy and in…NCT03910660·San Francisco, California and 11 others

RecruitingTesting Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL TrialThis randomized phase III trial examines whether lengthening the dosage interval in an adaptive manner for the prostate cancer drug lutetium 177 Lu PSMA RLT improves quality of…NCT07200830·Anchorage, Alaska and 128 others

CompletedA Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate CancerTo determine: * Anti-tumor activity of IPI-504 in 2 groups of subjects with hormone resistant prostate cancer.NCT00564928·San Bernardino, California and 9 others

CompletedS0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone MetastasesRATIONALE: Gathering information about how often osteonecrosis of the jaw occurs in patients receiving zoledronic acid for bone metastases may help doctors learn more about the…NCT00874211·Anniston, Alabama and 452 others

CompletedA Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer PatientsThis is a study to compare the efficacy and safety of 3 doses of DR-2031 to placebo when used as "add-on" therapy for prostate cancer patients with hot flashes following surgical…NCT00196339·Birmingham, Alabama and 117 others

CompletedUltrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation TherapyRATIONALE: Implant radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells.NCT00450411·Phoenix, Arizona and 16 others

Active not recruitingA Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPCThe purpose of this study is to evaluate the efficacy and safety of AAA617 alone (Lutetium \[177Lu\] vipivotide tetraxetan) and in combination with an Androgen Receptor Pathway…NCT05849298·Denver, Colorado and 30 others

CompletedStudy of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate CancerProtocol G200712 is a Phase II, exploratory study to assess the effects of GTx-758 on serum prostate specific antigen (PSA) response ans serum PSA progression in men with…NCT01615120·Burbank, California and 25 others

SuspendedThe Plenaxis® Experience StudyPraecis is currently conducting a 2000 patient Experience Study; this is a Phase IV commitment postmarketing safety study in the Food and Drug Administration (FDA) indicated…NCT00103623·Birmingham, Alabama and 59 others

TerminatedContributions to Hypertension With Androgen Deprivation TherapyThis study plans to learn more about contributors to high blood pressure in men who undergo androgen deprivation therapy (ADT) to treat prostate cancer.NCT05700903·Aurora, Colorado

CompletedStudy of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100This study will evaluate the effect of cabozantinib compared to prednisone on overall survival in men with previously treated metastatic castration-resistant prostate cancer with…NCT01605227·Birmingham, Alabama and 263 others

RecruitingA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsThe purpose of this study is to find out whether the study drug, LY4052031, is safe, tolerable and effective in participants with advanced, or metastatic solid tumors including…NCT06465069·Duarte, California and 38 others

PreviousPage 9 of 19Next

Other Conditions in Colorado

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma